
Zydus Lifesciences Limited has informed the Exchange about press release dated 10-Dec-2022 titled Zydus receives two final approvals from the USFDA for Silodosin capsules and Pregabalin capsules
Filed with NSE ·

Zydus Lifesciences Limited has informed the Exchange about press release dated 10-Dec-2022 titled Zydus receives two final approvals from the USFDA for Silodosin capsules and Pregabalin capsules
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences